Department of Dermatology

The simultaneous siRNA-mediated downregulation of inhibitory receptors to improve CAR-T cell immunotherapy of melanoma (2017) Simon B, Harrer D, Weide B, Schuler G, Schuler-Thurner B, Dörrie J, Schaft N, Uslu U Conference contribution Psoriasis - Occurrence and Reality: Disease of the Psoriasis Group (2017) Leupolz S, Sticherling M Conference contribution Psoriasis vulgaris as Manifestation of Immune Reconstitution in Patients with Hepatitis C under Treatment with Ledipasvir/Sofosbuvir (2017) Heppt F, Sticherling M Conference contribution Lungs Ailment - other Comorbidity of the Psoriasis? (2017) Moreira A, Sticherling M Conference contribution PASI <= 2 corresponds to PASI 90, irrespective of baseline severity: A post-hoc analysis of the PRIME-study (2017) Reich K, Sieder C, Bachhuber T, Melzer N, Sticherling M Conference contribution Look-alikes with opposite consequences: Cutaneous Botryomycosis presenting as cutaneous metastases in a patient with a history of metastatic lung cancer (2017) Bosch-Voskens C, Woerl P, Kiesewetter F, Schliep S Conference contribution Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibition (2017) Heppt M, Heinzerling L, Kaehler K, Forschner A, Kirchberger M, Loquai C, Meissner M, et al. Conference contribution Psoriasis in children: a single-centre analysis (2017) Heppt F, Raap J, Sticherling M Conference contribution RNA-transfection of gamma/delta T cells with a chimeric antigen receptor or an alpha/ss T-cell receptor: a safer alternative to genetically engineered alpha/ss T cells for the immunotherapy of melanoma (2017) Harrer D, Simon B, Fujii SI, Kanako S, Uslu U, Schuler G, Gerer KF, et al. Conference contribution FRA-1 TRANSCRIPTION FACTOR EXPRESSION IN MACROPHAGES FOSTER INFLAMMATION DURING RHEUMATOID ARTHRITIS DEVELOPMENT (2017) Hannemann N, Schnelzer A, Jordan J, Eberhardt M, Schleicher U, Hueber A, Reid S, et al. Conference contribution